TXNIP aggravates cardiac fibrosis and dysfunction after myocardial infarction in mice by enhancing the TGFB1/Smad3 pathway and promoting NLRP3 inflammasome activation

MLA

Zhang Yan, et al. “TXNIP Aggravates Cardiac Fibrosis and Dysfunction after Myocardial Infarction in Mice by Enhancing the TGFB1/Smad3 Pathway and Promoting NLRP3 Inflammasome Activation.” Acta Biochimica et Biophysica Sinica, vol. 55, Oct. 2023, pp. 1950–60. EBSCOhost, https://doi.org/10.3724/abbs.2023150.

APA

Zhang Yan, Wang Jin, Wang Xuejiao, Li Aiyun, Lei Zhandong, Li Dongxue, Xing Dehai, Zhang Yichao, Su Wanzhen, & Jiao Xiangying. (2023). TXNIP aggravates cardiac fibrosis and dysfunction after myocardial infarction in mice by enhancing the TGFB1/Smad3 pathway and promoting NLRP3 inflammasome activation. Acta Biochimica et Biophysica Sinica, 55, 1950–1960. https://doi.org/10.3724/abbs.2023150

Chicago

Zhang Yan, Wang Jin, Wang Xuejiao, Li Aiyun, Lei Zhandong, Li Dongxue, Xing Dehai, Zhang Yichao, Su Wanzhen, and Jiao Xiangying. 2023. “TXNIP Aggravates Cardiac Fibrosis and Dysfunction after Myocardial Infarction in Mice by Enhancing the TGFB1/Smad3 Pathway and Promoting NLRP3 Inflammasome Activation.” Acta Biochimica et Biophysica Sinica 55 (October): 1950–60. doi:10.3724/abbs.2023150.